These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18285424)

  • 1. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations.
    Kristjansdottir G; Sandling JK; Bonetti A; Roos IM; Milani L; Wang C; Gustafsdottir SM; Sigurdsson S; Lundmark A; Tienari PJ; Koivisto K; Elovaara I; Pirttilä T; Reunanen M; Peltonen L; Saarela J; Hillert J; Olsson T; Landegren U; Alcina A; Fernández O; Leyva L; Guerrero M; Lucas M; Izquierdo G; Matesanz F; Syvänen AC
    J Med Genet; 2008 Jun; 45(6):362-9. PubMed ID: 18285424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.
    Kawasaki A; Kyogoku C; Ohashi J; Miyashita R; Hikami K; Kusaoi M; Tokunaga K; Takasaki Y; Hashimoto H; Behrens TW; Tsuchiya N
    Arthritis Rheum; 2008 Mar; 58(3):826-34. PubMed ID: 18311811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
    Dideberg V; Kristjansdottir G; Milani L; Libioulle C; Sigurdsson S; Louis E; Wiman AC; Vermeire S; Rutgeerts P; Belaiche J; Franchimont D; Van Gossum A; Bours V; Syvänen AC
    Hum Mol Genet; 2007 Dec; 16(24):3008-16. PubMed ID: 17881657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.
    Carmona FD; Martin JE; Beretta L; Simeón CP; Carreira PE; Callejas JL; Fernández-Castro M; Sáez-Comet L; Beltrán E; Camps MT; Egurbide MV; ; Airó P; Scorza R; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Schuerwegh AJ; Vonk MC; Voskuyl AE; Radstake TR; Martín J
    PLoS One; 2013; 8(1):e54419. PubMed ID: 23372721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies.
    Alonso-Perez E; Fernandez-Poceiro R; Lalonde E; Kwan T; Calaza M; Gomez-Reino JJ; Majewski J; Gonzalez A
    Arthritis Res Ther; 2013 Aug; 15(4):R82. PubMed ID: 23941291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome.
    Nordmark G; Kristjansdottir G; Theander E; Eriksson P; Brun JG; Wang C; Padyukov L; Truedsson L; Alm G; Eloranta ML; Jonsson R; Rönnblom L; Syvänen AC
    Genes Immun; 2009 Jan; 10(1):68-76. PubMed ID: 19092842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
    Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
    Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
    Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population.
    Kim YJ; Park JH; Kim I; Kim JO; Bae JS; Shin HD; Bae SC
    J Rheumatol; 2008 Nov; 35(11):2106-18. PubMed ID: 18843785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus.
    Hou G; Zhou T; Xu N; Yin Z; Zhu X; Zhang Y; Cui Y; Ma J; Tang Y; Cheng Z; Shen Y; Chen Y; Zou LH; Wang YF; Yin Z; Guo Y; Ding H; Ye Z; Shen N
    Arthritis Rheumatol; 2023 Apr; 75(4):574-585. PubMed ID: 36245280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.
    Löfgren SE; Yin H; Delgado-Vega AM; Sanchez E; Lewén S; Pons-Estel BA; Witte T; D'Alfonso S; Ortego-Centeno N; Martin J; Alarcón-Riquelme ME; Kozyrev SV
    J Rheumatol; 2010 Mar; 37(3):574-8. PubMed ID: 20080916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
    Miceli-Richard C; Comets E; Loiseau P; Puechal X; Hachulla E; Mariette X
    Arthritis Rheum; 2007 Dec; 56(12):3989-94. PubMed ID: 18050197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.
    Kottyan LC; Zoller EE; Bene J; Lu X; Kelly JA; Rupert AM; Lessard CJ; Vaughn SE; Marion M; Weirauch MT; Namjou B; Adler A; Rasmussen A; Glenn S; Montgomery CG; Hirschfield GM; Xie G; Coltescu C; Amos C; Li H; Ice JA; Nath SK; Mariette X; Bowman S; ; Rischmueller M; Lester S; Brun JG; Gøransson LG; Harboe E; Omdal R; Cunninghame-Graham DS; Vyse T; Miceli-Richard C; Brennan MT; Lessard JA; Wahren-Herlenius M; Kvarnström M; Illei GG; Witte T; Jonsson R; Eriksson P; Nordmark G; Ng WF; ; Anaya JM; Rhodus NL; Segal BM; Merrill JT; James JA; Guthridge JM; Scofield RH; Alarcon-Riquelme M; Bae SC; Boackle SA; Criswell LA; Gilkeson G; Kamen DL; Jacob CO; Kimberly R; Brown E; Edberg J; Alarcón GS; Reveille JD; Vilá LM; Petri M; Ramsey-Goldman R; Freedman BI; Niewold T; Stevens AM; Tsao BP; Ying J; Mayes MD; Gorlova OY; Wakeland W; Radstake T; Martin E; Martin J; Siminovitch K; Moser Sivils KL; Gaffney PM; Langefeld CD; Harley JB; Kaufman KM
    Hum Mol Genet; 2015 Jan; 24(2):582-96. PubMed ID: 25205108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-marker haplotype in the IRF5 gene is associated with inflammatory bowel disease in a North American cohort.
    Gathungu G; Zhang CK; Zhang W; Cho JH
    Genes Immun; 2012 Jun; 13(4):351-5. PubMed ID: 22257839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.